난소적출로 유발된 갱년기장애 마우스 모델에서 毓麟珠 열수 추출물의 증상 개선 효과
Yuklinzu Aqueous Extracts Ameliorate Experimental Climacterium Symptoms Induced by Ovariectomy in Mouse
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The object of this study was to observe the complex anti-climacterium potentials of Yuklinzu aqueous extracts (YLZ), using bilateral ovariectomy (OVX) female ddY mice similar to women postmenopausal symptoms, as including cardiovascular diseases, obesity, hyperlipidemia, osteoporosis and hepatic steatosis. Methods: In order to evaluate anti-climacterium effects of YLZ, six groups of mice were used; sham control, OVX control, 17β-estradiol, YLZ 500, 250 and 125 mg/kg treated groups. Since 28 days after bilateral OVX surgery, YLZ were administered orally for 84 days, once a day. And then we evaluated anti-climacterium effects divided into five categories; estrogenic effects, anti-obesity, hypolipidemic effects, hepatoprotective effects and anti-osteoporotic effects. The results of YLZ were compared with 17β-estradiol 0.03 μg/head/day subcutaneous treated OVX mice. Results: As a result of OVX, obvious changes related to the estrogen-deficient menopausal symptoms - obesity, hyperlipidemia, hepatic steatosis and osteoporosis were displayed in mice. However, these menopausal symptoms induced by OVX were significantly inhibited by 84 days of consecutive treatment of 17β-estradiol, YLZ 500, 250 and 125 mg/kg, respectively. Especially, YLZ showed obvious dose-dependent inhibitory activities on the OVX-induced climacterium changes in mice, and YLZ 500 mg/kg showed comparable inhibitory effects against menopausal symptoms in comparison with those of 17β-estradiol 0.03 μg/head/day subcutaneous treatment. Conclusions: The results suggest that oral administration of YLZ 500, 250 and 125 mg/kg has obvious dose-dependent favorable anti-climacterium effects in OVX mice. Especially, YLZ 500 mg/kg showed comparable inhibitory effects against menopausal symptoms in comparison with those of 17β-estradiol 0.03 μg/head/day subcutaneous treatment.
Abstract
Objectives: The object of this study was to observe the complex anti-climacterium potentials of Yuklinzu aqueous extracts (YLZ), using bilateral ovariectomy (OVX) female ddY mice similar to women postmenopausal symptoms, as including cardiovascular diseases, obesity, hyperlipidemia, osteoporosis and hepatic steatosis. Methods: In order to evaluate anti-climacterium effects of YLZ, six groups of mice were used; sham control, OVX control, 17β-estradiol, YLZ 500, 250 and 125 mg/kg treated groups. Since 28 days after bilateral OVX surgery, YLZ were administered orally for 84 days, once a day. And then we evaluated anti-climacterium effects divided into five categories; estrogenic effects, anti-obesity, hypolipidemic effects, hepatoprotective effects and anti-osteoporotic effects. The results of YLZ were compared with 17β-estradiol 0.03 μg/head/day subcutaneous treated OVX mice. Results: As a result of OVX, obvious changes related to the estrogen-deficient menopausal symptoms - obesity, hyperlipidemia, hepatic steatosis and osteoporosis were displayed in mice. However, these menopausal symptoms induced by OVX were significantly inhibited by 84 days of consecutive treatment of 17β-estradiol, YLZ 500, 250 and 125 mg/kg, respectively. Especially, YLZ showed obvious dose-dependent inhibitory activities on the OVX-induced climacterium changes in mice, and YLZ 500 mg/kg showed comparable inhibitory effects against menopausal symptoms in comparison with those of 17β-estradiol 0.03 μg/head/day subcutaneous treatment. Conclusions: The results suggest that oral administration of YLZ 500, 250 and 125 mg/kg has obvious dose-dependent favorable anti-climacterium effects in OVX mice. Especially, YLZ 500 mg/kg showed comparable inhibitory effects against menopausal symptoms in comparison with those of 17β-estradiol 0.03 μg/head/day subcutaneous treatment.
참고문헌 (37)
- The Society of Korean Medicine Obstetrics and Gynecology, "Korean Medicine Obstetrics & Gynecology. Vol 2", pp.258~280 (2021), Euiseongdang
- Beral V, "Endometrial cancer and hormone-replacement therapy in the Million Women Study", Lancet, 365(9470), pp.1543~1551 (2005)
- Taku K, "Soy isoflavones lower serum total and LDL cholesterol in humans : a meta-analysis of 11 randomized controlled trials", Am J Clin Nutr, 85(4), pp.1148~1156 (2007)
- Ma DF, "Soy isoflavone intake increases bone mineral density in the spine of menopausal women : meta-analysis of randomized controlled trials", Clin Nutr, 27(1), pp.57~64 (2008)
- Zhang JB, "Complete Compendium of Zhang Jingyue", pp.692~693 (1996), China Press of Traditional Chinese Medicine
- Choi SS, "Studies on the effects of Yuklinzu on the ovulation and ovary in rats", The Journal of Oriental Gynecology, 12(2), pp.117~133 (1999)
- Seong YS, "Effects of Yuklinju on in vitro fertilization and embryo transfer", The Journal of Oriental Gynecology, 12(1), pp.161~184 (1999)
- 최상순, "毓麟珠가 卵巢摘出 白鼠의 骨多孔症에 미치는 영향", 동의생리병리학회지, 16(4), pp.26~800 (2002), 한의병리학회
- Kang SJ, "Selection of the optimal herbal compositions of red clover and pomegranate according to their protective effect against climacteric symptoms in ovariectomized mice", Nutrients, 8(8), pp.447~ (2016)
- Kang SJ, "Anti-climacterium effects of pomegranate concentrated solutions in ovariectomized ddY mice", Exp Ther Med, 13(4), pp.1249~1266 (2017)
- Yamaguchi K, "Suppressive effect of norzoanthamine hydrochloride on experimental osteoporosis in ovariectomized mice", Biol Pharm Bull, 22(9), pp.920~924 (1999)
- Han SY, "Ostreae Testa prevent ovariectomy-induced bone loss in mice by osteoblast activations", J Ethnopharmacol, 114(3), pp.400~405 (2007)
- Chiba H, "Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice", J Nutr, 133(6), pp.1892~1897 (2003)
- Murakami A, "Citrus nobiletin suppresses bone loss in ovariectomized ddY mice and collagen-induced arthritis in DBA", 1J mice : possible involvement of receptor activator of NF-kappaB ligand(RANKL)-induced osteoclastogenesis regulation, 2007, pp.30(3), 179~192
- Tousen Y, "Resistant starch promotes equol production and inhibits tibial bone loss in ovariectomized mice treated with daidzein", Metabolism, 60(10), pp.1425~1432 (2011)
- Cho CS, "Anti-osteoporotic effects of mixed compositions of extracellular polymers isolated from Aureobasidium pullulans and Textoria morbifera in ovariectomized mice", BMC Complement Altern Med, 18(1), pp.295~ (2018)
- Kang SJ, "Dried pomegranate potentiates anti-osteoporotic and antiobesity activities of red clover dry extracts in ovariectomized rats", Nutrients, 7(4), pp.2622~2647 (2015)
- Kang SJ, "Fermentation with Aquilariae Lignum enhances the antidiabetic activity of green tea in type II diabetic db", db mouse, 2014, pp.6(9), 3536~3571
- Levene A, "Pathological factors influencing excision of tumours in the head and neck. Part I", Clin Otolaryngol Allied Sci, 6(2), pp.145~151 (1981)
- 이상석, "What is the proper way to apply the multiple comparison test?", Korean Journal of Anesthesiology, 71(5), pp.353~360 (2018), 대한마취통증의학회
- Sauder DC, "An updated recommendation for multiple comparisons", Adv Methods Pract Psychol Sci, 2(1), pp.26~44 (2019)
- del Giorno C, "Effects of Trifolium pratense on the climacteric and sexual symptoms in postmenopause women", Rev Assoc Med Bras, 56(5), pp.558~562 (2010)
- Kuiper GG, "Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta", Endocrinology, 138(3), pp.863~870 (1997)
- Cornwell T, "Dietary phytoestrogens and health", Phytochem, 65(8), pp.995~1016 (2004)
- Geary N, "The estrogenic inhibition of eating. In: Handbook of behavioral neurobiology, Vol. 14", pp.307~345 (2004), Kluwer Academic
- Lutz TA, "Amylin may offer(more)help to treat postmenopausal obesity", Endocrinology, 152(1), pp.1~3 (2011)
- Ateba SB, "Eriosema laurentii De Wild(Leguminosae)methanol extract has estrogenic properties and prevents menopausal symptoms in ovariectomized Wistar rats", J Ethnopharmacol, 150(1), pp.298~307 (2013)
- Lampert C, "Effect of chronic administration of tamoxifen and", or estradiol on feeding behavior, palatable food and metabolic parameters in ovariectomized rats, 2013, pp.119, 17~24
- Couse JF, "Estrogen receptor null mice : what have we learned and where will they lead us?", Endocr Rev, 20(3), pp.358~417 (1999)
- Baker L, "The role of estrogen in cardiovascular disease", J Surg Res, 115(2), pp.325~344 (2003)
- Kim HM, "The effect of menopause on the metabolic syndrome among Korean women : the Korean National Health and Nutrition Examination Survey, 2001", Diabetes Care, 30(3), pp.701~706 (2007)
- Bottner M, "Effects of long-term treatment with 8-prenylnaringenin and oral estradiol on the GH-IGF-1 axis and lipid metabolism in rats", J Endocrinol, 198(2), pp.395~401 (2008)
- Di Croce L, "Independent behavior of rat liver LDL receptor and HMGCoA reductase under estrogen treatment", Biochem Biophys Res Commun, 224(2), pp.345~350 (1996)
- Lim DW, "Effects of dietary isoflavones from Puerariae radix on lipid and bone metabolism in ovariectomized rats", Nutrients, 5(7), pp.2734~2746 (2013)
- Kuo YJ, "Calcitonin inhibits SDCPinduced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis", PLoS One, 7(7), pp.e40272~ (2012)
- Syed Z, "Bone densitometry : applications and limitations", J Obstet Gynaecol Can, 24(6), pp.476~484 (2002)
- Heikkinen T, "Effects of long-term ovariectomy and estrogen treatment on maze learning in aged mice", Exp Gerontol, 39(9), pp.1277~1283 (2004)